APEX1 and non-small cell lung carcinoma: The results demonstrate that a low‐expression level of APE1 is important in maintaining the epithelial phenotype in EGFR‐TKI‐sensitive cells, while elevated APE1 facilitates EMT during the development of acquired resistance to EGFR‐TKIs in NSCLC.